Healthcare · Medical - Devices
Price
$19.98
Market Cap
$758.1M
Employees
281
Beta
0.84
Avg Volume
303,919
CEO
Xingjuan Chao
Business Description
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Business History
Price Overview
Last updated: Jun 27, 2026 10:02am (just now)$19.98
+0.25 (+1.27%)
Day Range
$19.60 – $20.76
52-Week Range
$10.85 – $24.33
50-Day MA
$18.99
200-Day MA
$17.67
Volume
1,128,598.00
Analyst Price Targets
Low
$25.00
Consensus
$25.00
High
$25.00
(3 analysts)
Share Structure
Outstanding
37,942,700.00
Float
24,503,205.00
Free Float
64.6%
Normal free float
— 64.6% of shares trade freely, ~35.4% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-13.68
Stock Price: $19.98
EPS (Diluted): -1.46
EPS (Diluted): -1.46
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
5.16
Stock Price: $19.98
Total Equity: $155.34M
Shares: 36,542,048
Total Equity: $155.34M
Shares: 36,542,048
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-12.83
Market Cap: $758.10M
Total Debt: $19.81M
Cash: $40.48M
EBITDA: -$50.18M
Total Debt: $19.81M
Cash: $40.48M
EBITDA: -$50.18M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$783.2M
Market Cap: $758.10M
Total Debt: $19.81M
Cash: $40.48M
Total Debt: $19.81M
Cash: $40.48M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
9.00
Stock Price: $19.98
Revenue: $89.06M
Shares: 36,542,048
Revenue: $89.06M
Shares: 36,542,048
EV/Sales (Total value vs revenue — works when P/E can't)
API8.79
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
87.9%
Gross Profit: $78.27M
Revenue: $89.06M
Revenue: $89.06M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-65.6%
Operating Income: -$58.40M
Revenue: $89.06M
Revenue: $89.06M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-60.0%
Net Income: -$53.41M
Revenue: $89.06M
Revenue: $89.06M
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-38.2%
Net Income: -$53.41M
Total Equity: $155.34M
Total Equity: $155.34M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-39.8%
Operating Income: -$58.40M
Tax Rate: 0.0%
Equity: $155.34M
Total Debt: $19.81M
Cash: $40.48M
Tax Rate: 0.0%
Equity: $155.34M
Total Debt: $19.81M
Cash: $40.48M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
9.73
Current Assets: $186.72M
Current Liabilities: $19.19M
Current Liabilities: $19.19M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.13
Short-Term Debt: $0.00
Long-Term Debt: $19.81M
Total Debt: $19.81M
Total Equity: $155.34M
Long-Term Debt: $19.81M
Total Debt: $19.81M
Total Equity: $155.34M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$2.44
Revenue: $89.06M
Shares: 36,542,048
Shares: 36,542,048
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$4.25
Total Equity: $155.34M
Shares: 36,542,048
Shares: 36,542,048
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-1.14
Operating CF: -$40.81M
CapEx: -$767,000
Shares: 36,542,048
CapEx: -$767,000
Shares: 36,542,048
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $19.98
Stock Price: $19.98
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$53.41M
Net Income: -$53.41M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares CBLL against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 24, 2026 12:08am (3d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $25.9M | $45.2M | $65.4M | $89.1M |
| Cost of Revenue | $4.4M | $7.1M | $8.7M | $10.8M |
| Gross Profit | $21.5M | $38.2M | $56.8M | $78.3M |
| Operating Expenses | $57.5M | $68.2M | $96.5M | $136.7M |
| Operating Income | -$36.0M | -$30.0M | -$39.7M | -$58.4M |
| Net Income | -$37.2M | -$29.5M | -$40.5M | -$53.4M |
| EBITDA | -$35.1M | -$26.5M | -$37.3M | -$50.2M |
| EPS | $-1.59 | $-1.26 | $-3.39 | $-1.46 |
| EPS (Diluted) | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 24, 2026 12:08am (3d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $68.2M | $34.5M | $194.4M | $40.5M |
| Total Current Assets | $79.8M | $52.0M | $217.3M | $186.7M |
| Total Assets | $86.5M | $58.9M | $225.4M | $195.8M |
| Current Liabilities | $9.9M | $21.6M | $13.0M | $19.2M |
| Long-Term Debt | $12.7M | $0 | $19.6M | $19.8M |
| Total Liabilities | $172.9M | $171.2M | $34.2M | $40.5M |
| Total Equity | -$86.4M | -$112.3M | $191.2M | $155.3M |
| Retained Earnings | -$97.0M | -$126.5M | -$166.9M | -$220.4M |
Cash Flow (Annual)
Last updated: Jun 24, 2026 12:08am (3d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -$32.0M | -$29.2M | -$35.0M | -$40.8M |
| Capital Expenditure | $-516,000 | $-983,000 | -$1.3M | $-767,000 |
| Free Cash Flow | -$32.5M | -$30.1M | -$36.4M | -$41.6M |
| Acquisitions (net) | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — |
| Dividends Paid | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 |
| Net Change in Cash | $16.4M | -$33.7M | $159.9M | -$153.9M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 10:02am (just now)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$145.9M $143.5M – $147.2M
|
$186.9M $186.9M – $187.0M
|
$228.5M $225.7M – $231.0M
|
$278.5M $275.1M – $281.5M
|
| EBITDA |
-$99.2M -$100.1M – -$97.6M
|
-$127.1M -$127.1M – -$127.1M
|
-$155.4M -$157.1M – -$153.5M
|
-$189.4M -$191.4M – -$187.0M
|
| Net Income |
-$44.3M -$47.0M – -$32.9M
|
-$34.8M -$37.6M – -$23.7M
|
-$22.0M -$22.3M – -$21.6M
|
-$20.1M -$20.4M – -$19.8M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 24, 2026 12:08am (3d ago)| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue Growth | +74.5% | +44.7% | +36.1% |
| Gross Profit Growth | +77.6% | +48.7% | +37.9% |
| Operating Income Growth | +16.6% | -32.2% | -47.1% |
| Net Income Growth | +20.7% | -37.3% | -32.0% |
| EBITDA Growth | +24.4% | -40.8% | -34.5% |
Insider Trading (Recent)
Last updated: Jun 27, 2026 7:24am (2h ago)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-11 | Taylor Joseph Michael | S-Sale | 5,500.00 | $18.41 | $101,255 |
| 2026-06-08 | Chao Xingjuan | M-Exempt | 23,554.00 | $4.70 | $110,704 |
| 2026-06-08 | Chao Xingjuan | M-Exempt | 1,446.00 | $4.70 | $6,796 |
| 2026-06-08 | Chao Xingjuan | S-Sale | 23,554.00 | $18.33 | $431,745 |
| 2026-06-08 | Chao Xingjuan | M-Exempt | 1,446.00 | $4.70 | $6,796 |
| 2026-06-08 | Chao Xingjuan | M-Exempt | 23,554.00 | $4.70 | $110,704 |
| 2026-06-02 | Tammenoms Bakker Juliet | A-Award | 7,838.00 | $0.00 | $0 |
| 2026-06-02 | Parvizi Josef | A-Award | 7,838.00 | $0.00 | $0 |
| 2026-06-02 | Rogers Erica J. | A-Award | 7,838.00 | $0.00 | $0 |
| 2026-06-02 | BURKE WILLIAM W | A-Award | 7,838.00 | $0.00 | $0 |
| 2026-06-02 | Taylor Joseph Michael | A-Award | 7,838.00 | $0.00 | $0 |
| 2026-06-02 | ROBERTSON REBECCA B | A-Award | 7,838.00 | $0.00 | $0 |
| 2026-05-21 | Manni Joseph S. | S-Sale | 1,378.00 | $18.00 | $24,804 |
| 2026-03-10 | Manni Joseph S. | A-Award | 3,500.00 | $9.41 | $32,935 |
| 2026-05-21 | Foehr David | S-Sale | 987.00 | $18.00 | $17,766 |
| 2026-05-22 | Foehr David | S-Sale | 862.00 | $18.80 | $16,206 |
| 2026-05-21 | Woo Raymond | S-Sale | 1,966.00 | $18.00 | $35,388 |
| 2026-05-21 | Blumberg Scott | S-Sale | 1,387.00 | $18.00 | $24,966 |
| 2026-05-21 | Chao Xingjuan | S-Sale | 6,030.00 | $18.00 | $108,540 |
| 2026-05-05 | Chao Xingjuan | M-Exempt | 23,554.00 | $4.70 | $110,704 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for CBLL — it's generated by the pipeline (
market-narrative step).
No community reviews yet for CBLL.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30